Vasculitis & polymyalgia rheumatica

Incidence and Prevalence of Polymyalgia Rheumatica and Giant Cell Arteritis in a Healthcare Management Organization in Buenos Aires, Argentina

J RheumatolPublished Retrospective cohort study

Authors' conclusion

This is the first study of incidence and prevalence of PMR and GCA in Argentina. There were similarities and differences with cohorts from other parts of the world

Study context

Population
Members (age ≥ 50 yrs) of the Hospital Italiano Medical Care Program, Buenos Aires, Argentina, with continuous affiliation ≥ 1 year, January 2000 to December 20151,046,620 person-years (PY)
Participants
176,558 members
Exposure
Women vs Men
Outcome
Incidence and prevalence of PMR (2012 EULAR/ACR criteria) and GCA (ACR 1990 criteria)
Methodological detailsuniversity hospital-based health management organization, age ≥ 50 yrs
  • University hospital-based health management organization
  • Age ≥ 50 yrs

Main finding

As reported in the abstract

PMR incident cases
825
PMR IR overall
78.8 (95% CI 73.4-84.2)
PMR IR women
90.1 (95% CI 82.9-97.2)
PMR IR men
58.9 (95% CI 51.1-66.6)
Giant cell arteritis (GCA) incident cases
90
GCA IR overall
8.6 (95% CI 6.8-10.4)
GCA IR women
11.1 (95% CI 8.5-10.6)
GCA IR men (2.2-6.3)
4.2

Observational data: associations, not effects.

Further findings

Prevalence of PMR and GCA (per 100,000) on January 1, 2015

Population for prevalence
80,335
Prevalent PMR cases
205
Prevalent GCA cases
23
PMR prevalence overall
255 (95% CI 220-290)
PMR prevalence women
280 (95% CI 234-325)
PMR prevalence men
209 (95% CI 150-262)
GCA prevalence overall
28.6 (95% CI 16.9-40.3)
GCA prevalence women
36.4 (95% CI 20.1-52.8)
GCA prevalence men
14.2 (95% CI 0.3-28.1)

Original publication

Incidence and Prevalence of Polymyalgia Rheumatica and Giant Cell Arteritis in a Healthcare Management Organization in Buenos Aires, Argentina. J Rheumatol. Published 1 September 2022. doi:10.3899/jrheum.220084

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.